-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Merck Enters Into Exclusive Global License Agreement With Scibrunch Therapeutics For Spr2015, An Investigational Oral Kras G12d (On) Inhibitor

Reuters·09/28/2026 10:46:32

Please log in to view news